Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Revenue: 2017-2024

Historic Revenue for Puma Biotechnology (PBYI) over the last 8 years, with Dec 2024 value amounting to $230.5 million.

  • Puma Biotechnology's Revenue fell 32.36% to $54.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $212.0 million, marking a year-over-year decrease of 12.96%. This contributed to the annual value of $230.5 million for FY2024, which is 2.19% down from last year.
  • According to the latest figures from FY2024, Puma Biotechnology's Revenue is $230.5 million, which was down 2.19% from $235.6 million recorded in FY2023.
  • In the past 5 years, Puma Biotechnology's Revenue registered a high of $253.2 million during FY2021, and its lowest value of $225.1 million during FY2020.
  • Over the past 3 years, Puma Biotechnology's median Revenue value was $235.6 million (recorded in 2023), while the average stood at $238.7 million.
  • Per our database at Business Quant, Puma Biotechnology's Revenue decreased by 17.32% in 2020 and then rose by 12.46% in 2021.
  • Puma Biotechnology's Revenue (Yearly) stood at $225.1 million in 2020, then climbed by 12.46% to $253.2 million in 2021, then fell by 1.25% to $250.0 million in 2022, then fell by 5.75% to $235.6 million in 2023, then decreased by 2.19% to $230.5 million in 2024.